跳至主要内容
临床试验/NCT02965196
NCT02965196Unknown不适用

Dexamethasone Therapy for Low Back Pain

Hillel Yaffe Medical Center1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
60
试验地点
1
主要终点
Pain Reduction

研究概览

简要总结

The study will evaluate the efficacy of IV Dexamethasone in treatment low back pain as an adjunct to analgesics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • No "red flags" of serious spinal pathology
  • Normal neurological examination
  • Indication for opioid analgesia based on our pain management protocol
  • No known hypersensitivity to the medication
  • Ability to provide informed consent

排除标准

  • Pregnancy
  • All others who do not meet inclusion criteria

研究组 & 干预措施

Dexamethasone Therapy

Active Comparator

Three consecutive doses of IV Dexamethasone with be administered over three days. The doses will be tapered according to the following: 1st dose, 26mg., 2nd dose, 20mg., and the third dose will be 10 mg. Each dose will be administered over 24 hours in a slow drip, in a 100cc. normal saline bag (0.9%).

干预措施: IV Dexamethasone Therapy (Drug)

Placebo Therapy

Placebo Comparator

Three consecutive doses of 100cc IV normal saline (0.9%), will be administered over three days. Each dose will be administered over 24 hours in a slow drip.

干预措施: IV Normal Saline (NaCl 0.9%) (Other)

结局指标

主要结局

Pain Reduction

时间窗: Four days

Pain will be measured according to the Visual Analog Scale throughout the treatment.

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Dexamethasone Therapy for Low Back Pain | 临床试验